FDA Challenges ZymoGenetics' Safety Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency takes issue with part of the better-than-bovine thrombin boast.
You may also be interested in...
ZymoGenetics Claims Competitor's Product Poses Serious Patient Safety Issue
As it tries to build market share for Recothrom, ZymoGenetics files Citizen's Petition asking FDA to remove its top competitor from the market.
ZymoGenetics Claims Competitor's Product Poses Serious Patient Safety Issue
As it tries to build market share for Recothrom, ZymoGenetics files Citizen's Petition asking FDA to remove its top competitor from the market.
Advertising Citations Reach Record High: Another Way To Regulate Pharma?
FDA's Division of Drug Marketing, Advertising and Communications has sent half of this year's citations for misleading advertising in the past month